The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
IMS 2024 | Abnormal serum immunofixation patterns following BCMA CAR-T in multiple myeloma
Mateo Mejia Saldarriaga, MD, Weill Cornell Medicine, New York, NY, discusses the phenomenon of abnormal serum immunofixation patterns (ASIPs) following BCMA CAR-T in multiple myeloma. In their study of roughly 45 patients, ASIPs occurred frequently and correlated with higher immunoglobulin levels. Dr Saldarriaga emphasizes the need for further research to clarify the clinical significance of this. This interview took place at the 21st International Myeloma Society (IMS) Annual Meeting, held in Rio de Janeiro, Brazil.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
